Trial site
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie
- 133running trials
- 38closed trials
The trials here
What the 171 trials at this site are about, from their registry records.
- Conditions
- Myasthenia gravis12 trials
- Prostate cancer10 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)9 trials
- Metastatic breast cancer9 trials
- Multiple sclerosis9 trials
- Colorectal cancer8 trials
- Gastric and oesophageal cancer8 trials
- Liver and biliary tract cancer8 trials
- Myeloproliferative neoplasms7 trials
- High blood pressure6 trials
- Multiple myeloma6 trials
- Triple-negative breast cancer6 trials
- and 55 more
- Phase
- Phase 397 trials
- Phase 252 trials
- Phase 16 trials
- Phase 2/36 trials
- Phase 1/25 trials
- Phase 45 trials
- Status
- Recruiting61 trials
- Active, not recruiting48 trials
- Completed38 trials
- Not yet recruiting24 trials
- Lead sponsor
- AstraZeneca16 trials
- Hoffmann-La Roche11 trials
- Sanofi8 trials
- Immunovant Sciences GmbH7 trials
- Novartis Pharmaceuticals6 trials
- and 86 more
Running trials
Recruiting
Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
Recruiting
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Active, not recruiting
Study of an On-Body Injection System for Home Use of Ocrelizumab in People with Multiple Sclerosis
Recruiting
Recruiting
A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruiting
Not yet recruiting
Recruiting
Recruiting
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Recruiting
Active, not recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
Active, not recruiting
Phase IIB Study of PHENOGENE-1A (Cromolyn) as an Adjuvant Therapy in Mild to Moderate ALS
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
Recruiting
Enrolling by invitation
Recruiting
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Active, not recruiting
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Recruiting
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Showing 50 of 133.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myasthenia gravis7 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)6 recruiting
- Colorectal cancer6 recruiting
- Prostate cancer6 recruiting
- Chronic lymphocytic leukaemia5 recruiting
- Liver and biliary tract cancer5 recruiting
- Pancreatic cancer5 recruiting
- Gastric and oesophageal cancer4 recruiting
- Hodgkin lymphoma4 recruiting
- Macular degeneration4 recruiting
- Ovarian cancer4 recruiting
- Acute myeloid leukaemia3 recruiting
- Fatty liver disease (MASLD/MASH)3 recruiting
- Graves' disease3 recruiting
- Lupus (SLE)3 recruiting
- Multiple myeloma3 recruiting
- Multiple sclerosis3 recruiting
- Myeloproliferative neoplasms3 recruiting
- Atrial fibrillation2 recruiting
- Chronic kidney disease2 recruiting
- Chronic myeloid leukaemia2 recruiting
- Dermatomyositis and polymyositis (myositis)2 recruiting
- Endometrial cancer2 recruiting
- High blood pressure2 recruiting
- Metastatic breast cancer2 recruiting
- Myelodysplastic syndromes2 recruiting
- Neuroendocrine tumours2 recruiting
- Parkinson disease2 recruiting
- Rheumatoid arthritis2 recruiting
- Sjögren's disease2 recruiting
- Stroke2 recruiting
- Triple-negative breast cancer2 recruiting
- Alzheimer disease1 recruiting
- Bladder cancer1 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Childhood cancers1 recruiting
- Cushing's syndrome1 recruiting
- Dystonia1 recruiting
- Haemophilia1 recruiting
- Head and neck cancer1 recruiting
- Heart failure1 recruiting
- HIV1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Nephrotic syndrome1 recruiting
- Obesity1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema
Active, not recruiting
Completed
ZN-c3 in Adult Participants With Metastatic Colorectal Cancer
Completed
Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP.
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Phase 3 Study of Pembrolizumab/Placebo plus Enzalutamide plus ADT in mHSPC
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Active, not recruiting
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026